JXSB2100015 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Supplementary Application | 2021-02-23 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd;BSP Pharmaceuticals Srl | In Review | 2021-02-22 | view |
JXSL2100007 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Import Drug Application | 2021-01-13 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2021-01-12 | view |
JXSL2000182 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Import Drug Application | 2020-10-15 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2020-10-14 | view |
JXSL2000144 | sacituzumab govitecan | | Injection | Biological Products(2.2) | Import Drug Application | 2020-08-26 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2020-08-25 | view |
JXSL2000014 | sacituzumab govitecan | | Injection | Biological Products | Import Drug Application | 2020-01-22 | 云顶药业(苏州)有限公司 | Everest Medicines (Suzhou) Inc;Everest Medicines II(HK)Ltd | In Review | 2020-01-21 | view |